JAK1, Janus kinase 1, 3716

N. diseases: 239; N. variants: 41
Disease: Steroid Refractory Graft Versus Host Disease ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C4687714
Disease: Steroid Refractory Graft Versus Host Disease
Steroid Refractory Graft Versus Host Disease 		0.010 Biomarker disease BEFREE Ruxolitinib, a selective JAK1/2 inhibitor, has recently gained favor as a second-line approach in patients with steroid-refractory cGVHD. 30201397 2019